{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:48:35Z","timestamp":1794523715417,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000504"],"award-info":[{"award-number":["82000504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973578"],"award-info":[{"award-number":["81973578"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204893"],"award-info":[{"award-number":["82204893"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dysregulation of gut microbiota\u2013host bile acid (BA) co-metabolism is a critical pathogenic factor of diarrhea-predominant irritable bowel syndrome (IBS-D). Traditional Chinese Medicine (TCM), instructed by pattern differentiation, is effective in treating IBS-D, in which liver depression and spleen deficiency (LDSD) is the most prevalent pattern. Still, it is unclear the linkage between the LDSD pattern and the BA metabolic phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aimed to uncover the biological basis of the LDSD pattern from the BA metabolic perspective.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Patients with IBS-D completed questionnaires regarding the irritable bowel severity scoring system (IBS-SSS), stool frequency, Stool Bristol scale, and Self-Rating Scales of mental health. Fasting blood and morning feces were collected to analyze the gut metagenome and BA-related indices\/metabolites.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IBS-D patients with LDSD had a higher incidence of BA overexcretion (41% vs. 23% non-LDSD) with significant elevations in fecal total BAs and serum BA precursor 7\u03b1-hydroxy-4-cholesten-3-one levels. Compared to controls or non-LDSD patients, LDSD patients had a featured fecal BA profile, with higher proportions of deoxycholic acid (DCA), 7-ketodeoxycholic acid, and lithocholic acid. It is consistent with the BA-metabolizing genomic changes in the LDSD gut microbiota characterized by overabundances of 7-dehydroxylating bacteria and BA-inducible genes (\n                      <jats:italic>baiCD\/E\/H<\/jats:italic>\n                      ). The score of bowel symptoms (stool frequency and abdominal pain) showing greater severity in the LDSD pattern were positively correlated with\n                      <jats:italic>bai<\/jats:italic>\n                      -expressing bacterial abundances and fecal DCA levels separately.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We clarified a differed BA metabolic phenotype in IBS patients with LDSD, which closely correlates with the severity of bowel symptoms. It demonstrates that gut microbiota and host co-metabolism of BAs would provide crucial insight into the biology of the LDSD pattern and its internal relationship with IBS progression.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-023-00795-9","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T11:03:13Z","timestamp":1689764593000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Altered gut microbiota\u2013host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern"],"prefix":"10.1186","volume":"18","author":[{"given":"Liqing","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaozhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixiang","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shujun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L. D.","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxiang","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4932-499X","authenticated-orcid":false,"given":"Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"issue":"8","key":"795_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","volume":"17","author":"CJ Black","year":"2020","unstructured":"Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473\u201386. https:\/\/doi.org\/10.1038\/s41575-020-0286-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"795_CR2","doi-asserted-by":"publisher","first-page":"e12897","DOI":"10.1111\/nmo.12897","volume":"29","author":"Y Long","year":"2017","unstructured":"Long Y, Huang Z, Deng Y, Chu H, Zheng X, Yang J, et al. Prevalence and risk factors for functional bowel disorders in South China: a population based study using the Rome III criteria. Neurogastroenterol Motil. 2017;29(1):e12897. https:\/\/doi.org\/10.1111\/nmo.12897.","journal-title":"Neurogastroenterol Motil"},{"issue":"7","key":"795_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/17512433.2018.1494571","volume":"11","author":"A Zielinska","year":"2018","unstructured":"Zielinska A, Salaga M, Wlodarczyk M, Fichna J. Chronic abdominal pain in irritable bowel syndrome\u2014current and future therapies. Expert Rev Clin Pharmacol. 2018;11(7):729\u201339. https:\/\/doi.org\/10.1080\/17512433.2018.1494571.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"17","key":"795_CR4","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1007\/s40265-021-01634-7","volume":"81","author":"EV Wechsler","year":"2021","unstructured":"Wechsler EV, Shah ED. Diarrhea-predominant and constipation-predominant irritable bowel syndrome: current prescription drug treatment options. Drugs. 2021;81(17):1953\u201368. https:\/\/doi.org\/10.1007\/s40265-021-01634-7.","journal-title":"Drugs"},{"key":"795_CR5","doi-asserted-by":"publisher","first-page":"694741","DOI":"10.3389\/fphar.2021.694741","volume":"12","author":"H Zheng","year":"2021","unstructured":"Zheng H, Jin S, Shen YL, Peng WY, Ye K, Tang TC, et al. Chinese herbal medicine for irritable bowel syndrome: a meta-analysis and trial sequential analysis of randomized controlled trials. Front Pharmacol. 2021;12:694741. https:\/\/doi.org\/10.3389\/fphar.2021.694741.","journal-title":"Front Pharmacol"},{"issue":"2","key":"795_CR6","doi-asserted-by":"publisher","first-page":"e0192319","DOI":"10.1371\/journal.pone.0192319","volume":"13","author":"YK Dai","year":"2018","unstructured":"Dai YK, Li DY, Zhang YZ, Huang MX, Zhou YL, Ye JT, et al. Efficacy and safety of modified Tongxie Yaofang in diarrhea-predominant irritable bowel syndrome management: a meta-analysis of randomized, positive medicine-controlled trials. PLoS ONE. 2018;13(2):e0192319. https:\/\/doi.org\/10.1371\/journal.pone.0192319.","journal-title":"PLoS ONE"},{"key":"795_CR7","doi-asserted-by":"publisher","first-page":"7680963","DOI":"10.1155\/2019\/7680963","volume":"2019","author":"J Yan","year":"2019","unstructured":"Yan J, Miao ZW, Lu J, Ge F, Yu LH, Shang WB, et al. Acupuncture plus Chinese Herbal Medicine for irritable bowel syndrome with diarrhea: a systematic review and meta-analysis. Evid Based Complement Altern Med. 2019;2019:7680963. https:\/\/doi.org\/10.1155\/2019\/7680963.","journal-title":"Evid Based Complement Altern Med"},{"key":"795_CR8","doi-asserted-by":"publisher","first-page":"232147","DOI":"10.1155\/2013\/232147","volume":"2013","author":"Q Li","year":"2013","unstructured":"Li Q, Yang GY, Liu JP. Syndrome differentiation in Chinese herbal medicine for irritable bowel syndrome: a literature review of randomized trials. Evid Based Complement Altern Med. 2013;2013:232147. https:\/\/doi.org\/10.1155\/2013\/232147.","journal-title":"Evid Based Complement Altern Med"},{"key":"795_CR9","doi-asserted-by":"publisher","first-page":"821802","DOI":"10.3389\/fphar.2021.821802","volume":"12","author":"Q Liu","year":"2021","unstructured":"Liu Q, Shi Z, Zhang T, Jiang T, Luo X, Su X, et al. Efficacy and safety of Chinese Herbal Medicine Xiao Yao San in functional gastrointestinal disorders: a meta-analysis and trial sequential analysis of randomized controlled trials. Front Pharmacol. 2021;12:821802. https:\/\/doi.org\/10.3389\/fphar.2021.821802.","journal-title":"Front Pharmacol"},{"issue":"6","key":"795_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1056\/NEJMc1214185","volume":"368","author":"M Camilleri","year":"2013","unstructured":"Camilleri M. Peripheral mechanisms in irritable bowel syndrome. N Engl J Med. 2013;368(6):578\u20139. https:\/\/doi.org\/10.1056\/NEJMc1214185.","journal-title":"N Engl J Med"},{"key":"795_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-328515","author":"M Camilleri","year":"2022","unstructured":"Camilleri M, Boeckxstaens G. Irritable bowel syndrome: treatment based on pathophysiology and biomarkers. Gut. 2022. https:\/\/doi.org\/10.1136\/gutjnl-2022-328515.","journal-title":"Gut"},{"issue":"9","key":"795_CR12","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1016\/j.cgh.2021.11.035","volume":"20","author":"J BouSaba","year":"2022","unstructured":"BouSaba J, Sannaa W, McKinzie S, Vijayvargiya P, Chedid V, Wang XJ, et al. Impact of bile acid diarrhea in patients with diarrhea-predominant irritable bowel syndrome on symptoms and quality of life. Clin Gastroenterol Hepatol. 2022;20(9):2083-2090.e2081. https:\/\/doi.org\/10.1016\/j.cgh.2021.11.035.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"795_CR13","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1177\/1756283X10377126","volume":"3","author":"JR Walters","year":"2010","unstructured":"Walters JR, Pattni SS. Managing bile acid diarrhoea. Therap Adv Gastroenterol. 2010;3(6):349\u201357. https:\/\/doi.org\/10.1177\/1756283X10377126.","journal-title":"Therap Adv Gastroenterol"},{"issue":"5","key":"795_CR14","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.cgh.2016.11.012","volume":"15","author":"C Peleman","year":"2017","unstructured":"Peleman C, Camilleri M, Busciglio I, Burton D, Donato L, Zinsmeister AR. Colonic transit and bile acid synthesis or excretion in patients with irritable bowel syndrome-diarrhea without bile acid malabsorption. Clin Gastroenterol Hepatol. 2017;15(5):720-727.e721. https:\/\/doi.org\/10.1016\/j.cgh.2016.11.012.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"795_CR15","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.cgh.2012.05.006","volume":"10","author":"BS Wong","year":"2012","unstructured":"Wong BS, Camilleri M, Carlson P, McKinzie S, Busciglio I, Bondar O, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol. 2012;10(9):1009. https:\/\/doi.org\/10.1016\/j.cgh.2012.05.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"795_CR16","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI130976","volume":"130","author":"L Zhao","year":"2020","unstructured":"Zhao L, Yang W, Chen Y, Huang F, Lu L, Lin C, et al. A clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J Clin Invest. 2020;130(1):438\u201350. https:\/\/doi.org\/10.1172\/JCI130976.","journal-title":"J Clin Invest"},{"issue":"10","key":"795_CR17","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/ptr.4613","volume":"26","author":"H Sun","year":"2012","unstructured":"Sun H, Zhang A, Wang X. Potential role of metabolomic approaches for Chinese medicine syndromes and herbal medicine. Phytother Res. 2012;26(10):1466\u201371. https:\/\/doi.org\/10.1002\/ptr.4613.","journal-title":"Phytother Res"},{"key":"795_CR18","doi-asserted-by":"publisher","first-page":"1027628","DOI":"10.3389\/fphar.2022.1027628","volume":"13","author":"Y Pan","year":"2022","unstructured":"Pan Y, Guo J, Hu N, Xun Y, Zhang B, Feng Q, et al. Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases. Front Pharmacol. 2022;13:1027628. https:\/\/doi.org\/10.3389\/fphar.2022.1027628.","journal-title":"Front Pharmacol"},{"issue":"1","key":"795_CR19","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41598-018-24130-7","volume":"8","author":"Z Lin","year":"2018","unstructured":"Lin Z, Ye W, Zu X, Xie H, Li H, Li Y, et al. Integrative metabolic and microbial profiling on patients with Spleen-yang-deficiency syndrome. Sci Rep. 2018;8(1):6619. https:\/\/doi.org\/10.1038\/s41598-018-24130-7.","journal-title":"Sci Rep"},{"key":"795_CR20","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.02.031","author":"F Mearin","year":"2016","unstructured":"Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel disorders. Gastroenterology. 2016. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.031.","journal-title":"Gastroenterology"},{"issue":"11","key":"795_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jcm6110099","volume":"6","author":"BE Lacy","year":"2017","unstructured":"Lacy BE, Patel NK. Rome criteria and a diagnostic approach to irritable bowel syndrome. J Clin Med. 2017;6(11):99. https:\/\/doi.org\/10.3390\/jcm6110099.","journal-title":"J Clin Med"},{"key":"795_CR22","doi-asserted-by":"publisher","first-page":"9507674","DOI":"10.1155\/2020\/9507674","volume":"2020","author":"J Song","year":"2020","unstructured":"Song J, Yang L, Su S, Piao MY, Li BL, Liang LX, et al. The diagnosis performance of the TCM syndromes of irritable bowel syndrome by gastroenterologists based on modified simple criteria compared to TCM practitioners: a prospective, multicenter preliminary study. Evid Based Complement Altern Med. 2020;2020:9507674. https:\/\/doi.org\/10.1155\/2020\/9507674.","journal-title":"Evid Based Complement Altern Med"},{"issue":"2","key":"795_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395\u2013402. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.142318000.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"795_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/s0033-3182(71)71479-0","volume":"12","author":"WW Zung","year":"1971","unstructured":"Zung WW. A rating instrument for anxiety disorders. Psychosomatics. 1971;12(6):371\u20139. https:\/\/doi.org\/10.1016\/s0033-3182(71)71479-0.","journal-title":"Psychosomatics"},{"key":"795_CR25","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archpsyc.1965.01720310065008","volume":"12","author":"WW Zung","year":"1965","unstructured":"Zung WW. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63\u201370. https:\/\/doi.org\/10.1001\/archpsyc.1965.01720310065008.","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"795_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nbt.2942","volume":"32","author":"J Li","year":"2014","unstructured":"Li J, Jia H, Cai X, Zhong H, Feng Q, Sunagawa S, et al. An integrated catalog of reference genes in the human gut microbiome. Nat Biotechnol. 2014;32(8):834\u201341. https:\/\/doi.org\/10.1038\/nbt.2942.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"795_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nm.4358","volume":"23","author":"R Liu","year":"2017","unstructured":"Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859\u201368. https:\/\/doi.org\/10.1038\/nm.4358.","journal-title":"Nat Med"},{"key":"795_CR28","doi-asserted-by":"publisher","first-page":"6528","DOI":"10.1038\/ncomms7528","volume":"6","author":"Q Feng","year":"2015","unstructured":"Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6:6528. https:\/\/doi.org\/10.1038\/ncomms7528.","journal-title":"Nat Commun"},{"issue":"1","key":"795_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstrom","year":"2016","unstructured":"Wahlstrom A, Sayin SI, Marschall HU, Backhed F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41\u201350. https:\/\/doi.org\/10.1016\/j.cmet.2016.05.005.","journal-title":"Cell Metab"},{"issue":"10","key":"795_CR30","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","volume":"50","author":"JY Chiang","year":"2009","unstructured":"Chiang JY. Bile acids: regulation of synthesis. J Lipid Res. 2009;50(10):1955\u201366. https:\/\/doi.org\/10.1194\/jlr.R900010-JLR200.","journal-title":"J Lipid Res"},{"issue":"1","key":"795_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12974-021-02303-y","volume":"18","author":"H Li","year":"2021","unstructured":"Li H, Xiang Y, Zhu Z, Wang W, Jiang Z, Zhao M, et al. Rifaximin-mediated gut microbiota regulation modulates the function of microglia and protects against CUMS-induced depression-like behaviors in adolescent rat. J Neuroinflamm. 2021;18(1):254. https:\/\/doi.org\/10.1186\/s12974-021-02303-y.","journal-title":"J Neuroinflamm"},{"issue":"7","key":"795_CR32","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1365-2982.2009.01288.x","volume":"21","author":"M Camilleri","year":"2009","unstructured":"Camilleri M, Nadeau A, Tremaine WJ, Lamsam J, Burton D, Odunsi S, et al. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry. Neurogastroenterol Motil. 2009;21(7):734-e743. https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01288.x.","journal-title":"Neurogastroenterol Motil"},{"issue":"11","key":"795_CR33","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","volume":"7","author":"JR Walters","year":"2009","unstructured":"Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol. 2009;7(11):1189\u201394. https:\/\/doi.org\/10.1016\/j.cgh.2009.04.024.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"795_CR34","doi-asserted-by":"publisher","first-page":"G10","DOI":"10.1152\/ajpgi.00080.2015","volume":"309","author":"M Camilleri","year":"2015","unstructured":"Camilleri M, Carlson P, Acosta A, Busciglio I. Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion. Am J Physiol Gastrointest Liver Physiol. 2015;309(1):G10-20. https:\/\/doi.org\/10.1152\/ajpgi.00080.2015.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"795_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1586\/17474124.2014.851599","volume":"8","author":"M Camilleri","year":"2014","unstructured":"Camilleri M. Advances in understanding of bile acid diarrhea. Expert Rev Gastroenterol Hepatol. 2014;8(1):49\u201361. https:\/\/doi.org\/10.1586\/17474124.2014.851599.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"795_CR36","doi-asserted-by":"publisher","first-page":"906256","DOI":"10.3389\/fphar.2022.906256","volume":"13","author":"Z Li","year":"2022","unstructured":"Li Z, Zhao Y, Cheng J, Xu L, Wen X, Sun Y, et al. Integrated plasma metabolomics and gut microbiota analysis: the intervention effect of Jiawei Xiaoyao San on liver depression and spleen deficiency liver cancer rats. Front Pharmacol. 2022;13:906256. https:\/\/doi.org\/10.3389\/fphar.2022.906256.","journal-title":"Front Pharmacol"},{"issue":"03","key":"795_CR37","first-page":"150","volume":"2","author":"J Li","year":"2015","unstructured":"Li J, Bi L, Xia K, Gao K, Chen J, Guo S, et al. Biological basis of \u201cdepression with liver-qi stagnation and spleen deficiency syndrome\u201d: a digital gene expression profiling study. J Tradit Chin Med Sci. 2015;2(03):150\u20138.","journal-title":"J Tradit Chin Med Sci"},{"issue":"1","key":"795_CR38","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40168-019-0689-3","volume":"7","author":"A Heinken","year":"2019","unstructured":"Heinken A, Ravcheev DA, Baldini F, Heirendt L, Fleming RMT, Thiele I. Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease. Microbiome. 2019;7(1):75. https:\/\/doi.org\/10.1186\/s40168-019-0689-3.","journal-title":"Microbiome"},{"issue":"1","key":"795_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.chom.2022.11.006","volume":"31","author":"L Zhai","year":"2023","unstructured":"Zhai L, Huang C, Ning Z, Zhang Y, Zhuang M, Yang W, et al. Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis. Cell Host Microbe. 2023;31(1):33-44.e35. https:\/\/doi.org\/10.1016\/j.chom.2022.11.006.","journal-title":"Cell Host Microbe"},{"issue":"6103","key":"795_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1126\/science.1224820","volume":"338","author":"JC Arthur","year":"2012","unstructured":"Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120\u20133. https:\/\/doi.org\/10.1126\/science.1224820.","journal-title":"Science"},{"issue":"2","key":"795_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14(2):207\u201315. https:\/\/doi.org\/10.1016\/j.chom.2013.07.007.","journal-title":"Cell Host Microbe"},{"key":"795_CR42","doi-asserted-by":"publisher","first-page":"6467135","DOI":"10.1155\/2018\/6467135","volume":"2018","author":"Z Huang","year":"2018","unstructured":"Huang Z, Hou Z, Liu X, Liu F, Wu Y. Quantifying liver stagnation spleen deficiency pattern for diarrhea predominate irritable bowel syndromes using multidimensional analysis methods. Evid Based Complement Altern Med. 2018;2018:6467135. https:\/\/doi.org\/10.1155\/2018\/6467135.","journal-title":"Evid Based Complement Altern Med"},{"key":"795_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fpsyg.2019.00574","volume":"10","author":"J Ye","year":"2019","unstructured":"Ye J, Cai S, Cheung WM, Tsang HWH. An east meets west approach to the understanding of emotion dysregulation in depression: from perspective to scientific evidence. Front Psychol. 2019;10:574. https:\/\/doi.org\/10.3389\/fpsyg.2019.00574.","journal-title":"Front Psychol"},{"key":"795_CR44","doi-asserted-by":"publisher","first-page":"A19","DOI":"10.1136\/gutjnl-2020-IDDF.25","volume":"69","author":"LH Lee","year":"2020","unstructured":"Lee LH, Ser HL, Letchumanan V, Law JWF, Goh BH, Tan LTH. The role of gut microbiome in Traditional Chinese Medicine syndromes: focusing on the spleen deficiency syndrome. Gut. 2020;69:A19\u2013A19. https:\/\/doi.org\/10.1136\/gutjnl-2020-IDDF.25.","journal-title":"Gut"},{"issue":"8","key":"795_CR45","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/ar.24388","volume":"303","author":"XJ Li","year":"2020","unstructured":"Li XJ, Qiu WQ, Da XL, Hou YJ, Ma QY, Wang TY, et al. A combination of depression and liver Qi stagnation and spleen deficiency syndrome using a rat model. Anat Rec (Hoboken). 2020;303(8):2154\u201367. https:\/\/doi.org\/10.1002\/ar.24388.","journal-title":"Anat Rec (Hoboken)"},{"key":"795_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7902874","author":"WJ Lv","year":"2019","unstructured":"Lv WJ, Wu XL, Chen WQ, Li YF, Zhang GF, Chao LM, et al. The gut microbiome modulates the changes in liver metabolism and in inflammatory processes in the brain of chronic unpredictable mild stress rats. Oxid Med Cell Longev. 2019. https:\/\/doi.org\/10.1155\/2019\/7902874.","journal-title":"Oxid Med Cell Longev"},{"key":"795_CR47","doi-asserted-by":"publisher","first-page":"8873294","DOI":"10.1155\/2021\/8873294","volume":"2021","author":"S Sun","year":"2021","unstructured":"Sun S, Yang Y, Lin X, Chen P, Ye L, Zeng L, et al. Qiweibaizhu decoction treats diarrheal juvenile rats by modulating the gut microbiota, short-chain fatty acids, and the mucus barrier. Evid Based Complement Altern Med. 2021;2021:8873294. https:\/\/doi.org\/10.1155\/2021\/8873294.","journal-title":"Evid Based Complement Altern Med"},{"issue":"8","key":"795_CR48","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1172\/JCI106644","volume":"50","author":"HS Mekjian","year":"1971","unstructured":"Mekjian HS, Phillips SF, Hofmann AF. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J Clin Invest. 1971;50(8):1569\u201377. https:\/\/doi.org\/10.1172\/JCI106644.","journal-title":"J Clin Invest"},{"issue":"1","key":"795_CR49","doi-asserted-by":"publisher","first-page":"20436","DOI":"10.1038\/s41598-020-77374-7","volume":"10","author":"NM Sagar","year":"2020","unstructured":"Sagar NM, Duboc H, Kay GL, Alam MT, Wicaksono AN, Covington JA, et al. The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids. Sci Rep. 2020;10(1):20436. https:\/\/doi.org\/10.1038\/s41598-020-77374-7.","journal-title":"Sci Rep"},{"issue":"2","key":"795_CR50","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1096\/fj.201800935RR","volume":"33","author":"WT Li","year":"2019","unstructured":"Li WT, Luo QQ, Wang B, Chen X, Yan XJ, Qiu HY, et al. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor\/nerve growth factor\/transient receptor potential vanilloid 1 axis. FASEB J. 2019;33(2):2435\u201350. https:\/\/doi.org\/10.1096\/fj.201800935RR.","journal-title":"FASEB J"},{"key":"795_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.131712","author":"J Castro","year":"2019","unstructured":"Castro J, Harrington AM, Lieu T, Garcia-Caraballo S, Maddern J, Schober G, et al. Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity. JCI Insight. 2019. https:\/\/doi.org\/10.1172\/jci.insight.131712.","journal-title":"JCI Insight"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-023-00795-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-023-00795-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T11:04:02Z","timestamp":1689764642000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-023-00795-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["795"],"URL":"https:\/\/doi.org\/10.1186\/s13020-023-00795-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2827438\/v1","asserted-by":"object"}]},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"17 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}